UK needs a devices industry leader to avoid "pharma drift"
This article was originally published in Clinica
The UK medical devices industry is calling for the clear identification within the Medicines and Healthcare products Regulatory Agency (MHRA) of an individual who should be responsible for continuing to fight at European level for "commonsense and pragmatic solutions" to medical device regulatory problems, according to Malcolm Carlisle, group managing director of Eschmann Holdings.
You may also be interested in...
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.